Volume | 973,784 |
|
|||||
News | (1) | ||||||
Day High | 64.36 | Low High |
|||||
Day Low | 62.33 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Bio Techne Corporation | TECH | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
62.83 | 62.33 | 64.36 | 64.06 | 62.66 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
16,165 | 973,784 | $ 63.96 | $ 62,287,254 | - | 51.79 - 89.91 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:35:14 | 2 | $ 64.61 | USD |
Bio Techne Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
10.07B | 157.19M | - | 1.14B | 285.26M | 1.81 | 35.31 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Bio Techne News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TECH Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 62.45 | 64.585 | 61.79 | 63.01 | 981,346 | 1.61 | 2.58% |
1 Month | 70.75 | 71.27 | 61.16 | 65.85 | 965,725 | -6.69 | -9.46% |
3 Months | 66.68 | 78.745 | 61.16 | 69.71 | 1,065,234 | -2.62 | -3.93% |
6 Months | 61.37 | 78.745 | 51.79 | 67.74 | 1,149,540 | 2.69 | 4.38% |
1 Year | 77.90 | 89.91 | 51.79 | 72.13 | 1,024,176 | -13.84 | -17.77% |
3 Years | 108.6325 | 135.9625 | 51.79 | 80.52 | 616,455 | -44.57 | -41.03% |
5 Years | 47.86 | 135.9625 | 38.7925 | 77.79 | 441,001 | 16.20 | 33.85% |
Bio Techne Description
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. |